MedTrace Logo

Efficacy and Safety of Skin Care Product in Aging Facial Skin

NCT04015063 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2019-07-10

No results posted yet for this study

Summary

The purpose of this study is to assess the efficacy and safety of P29429-01 as a skin care product to manage skin aging in women subjects 40-65 years of age.

Conditions

  • Skin Aging

Interventions

OTHER

Anti-Aging Skin Care product

Primary Subjects will use P29429-01 as an anti-aging skin care product on full face twice a day for 12-week.

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Yi-Hua Liao, Ph.D · National Taiwan University Hospital

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-03-04
Primary Completion
2019-07-05
Completion
2019-12-13

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04015063 on ClinicalTrials.gov